Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis

From MaRDI portal
Publication:1794472

DOI10.1016/j.jtbi.2008.02.014zbMath1398.92120OpenAlexW2130321554WikidataQ51889731 ScholiaQ51889731MaRDI QIDQ1794472

Heinz Schättler, Urszula Łedzewicz-Kowalewska

Publication date: 15 October 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2008.02.014




Related Items (23)

Local controllability and optimal control for a model of combined anticancer therapy with control delaysOptimal Control of Cancer Treatments: Mathematical Models for the Tumor MicroenvironmentAsymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapyExistence of Solutions and Local Null Controllability for a Model of Tissue Invasion by Solid TumorsThe nature of Hopf bifurcation for the Gompertz model with delaysAnalysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delaysStability analysis of the family of tumour angiogenesis models with distributed time delaysOn an extension of a mathematical model for tumor anti-angiogenesisTumour growth control: analysis of alternative approachesOn dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapiesOptimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancerDelay Differential Equations in Bio-PopulationsOn assessing quality of therapy in non-linear distributed mathematical models for brain tumor growth dynamicsOptimal response to chemotherapy for a mathematical model of tumor-immune dynamicsOptimal Control Problem for Cancer Invasion Reaction–Diffusion SystemComputational modeling of tumor response to vascular-targeting therapies. I: ValidationAngiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued methodAnalysis of the Hopf bifurcation for the family of angiogenesis modelsOn the role of the objective in the optimization of compartmental models for biomedical therapiesOn the role of pharmacometrics in mathematical models for cancer treatmentsTumor Development Under Combination Treatments with Anti-angiogenic TherapiesOn optimal delivery of combination therapy for tumorsNumerical solution for a problem arising in angiogenic signalling



Cites Work


This page was built for publication: Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis